Download Free Medical Adverse Drug Reactions PowerPoint Presentation

Adverse Drug Reactions PowerPoint Presentation

DOWNLOAD MEDICAL POWERPOINT PRESENTATION

About This Presentation

Description : Check out this medical presentation on Pharmacology, which is titled "Adverse Drug Reactions", to know about the Adverse Drug Reactions. Adverse reactions (ARs) is any undesirable or unintended consequence of drug administration. They include all kinds of noxious effects – trivial, serious or even fatal.

Tags : Pharmacology, Adverse Drug Reactions

Published on : Jul 18, 2021 | Views : 2125 | Downloads : 8

Shareable Url :

Embed Code :

Comment

Transcript

Slide 1-

Adverse Drug Reactions (Summary) Assoc. Prof. Iv. Lambev E-mail: itlambev@mail.bg www.medpharm-sofia.eu
Slide 2-

Adverse reactions (ARs) is any undesirable or unintended consequence of drug administration. They include all kinds of noxious effects – trivial, serious or even fatal. All drugs are capable of producing ARs. Whenever a drug is given a risk is taken. The magnitude of risk has to be considered along with other therapeutic advantages in deciding whether or not to use a drug. ARs may develop promptly or only after prolonged medication or even after stoppage of the drug. An incidence of 10–25% ARs has been documented in different clinical studies. They are more common with multiple drug therapy and in elderly patients.
Slide 3-

It is convenient to classify drug ARs under the following headings: Type A (Augmented) reactions will occur in everyone if enough of the drug is given because they are due to excess of normal, predictable, dose-related, pharmacodynamic effects. Their common and skilled management reduces their incidence, e.g. postural hypotension, hypoglycemia, hypokalemia. Type A reactions also include side, secondary, and toxic effects of drugs.
Slide 4-

Type B (Bizarre) reactions will occur only in some people. They are not part of the normal pharmacology of the drug and are not dose-related. These effects may be predictable when the mechanism is known (though predictive tests may be expensive or impracticable), otherwise they can be unpredictable for the individual. The class includes unwanted effects due to inherited abnormalities (idiosyncrasy) and immunological processes (drug allergy).
Slide 5-

Type C (Chronic) reactions due to long-term exposure, e.g. analgesic nephropathy, dyskinesias with levodopa. Type D (Delayed) reactions following prolonged exposure, e.g. carcinogenesis or short-term exposure at a critical time, e.g. teratogenesis. Type E (Ending of use) reactions, where dicontinuation of chronic therapy is too abrupt, e.g. adrenal steroid causing rebound adrenocortical insufficiency, opioid causing the withdrawal syndrome. F (Failures) – unwanted drug interactions.
Slide 6-

Causes of drug ARs (1) The patient may be predisposed by age, genetic constitution, tendency to allergy, disease, personality, habits. (2) The drug. Anticancer agents are cytotoxic by nature. Some drugs, e.g. digoxin, have steep dose-response curves and small increments of a dose are more likely to induce augmented (type A) reactions. Other drugs, e.g. antimicrobials, have a ten- dency to cause allergy and may lead to bizarre (type B) reactions. Ingredients of a formulation, e.g. coloring, flavoring, sodium content, rather than the active drug may also cause ARs. (3) The prescriber. ARs may occur because a drug is used for an inappropriately long time (type C), at a critical phase in pregnancy (type D), is abruptly discontinued (type E) or given with other drugs (type F – unwanted drug interactions).
Slide 7-

Severity of adverse drug reactions has been graded as: Minor: No therapy or antidote required. Moderate: Requires change in drug therapy, specific treatment or prolongs hospital stay by at least one day. Severe: Potentially life threatening, causes permanent damage or requires intensive medical treatment. Lethal: Directly or indirectly contributes to death of the patient.
Slide 8-

Drug ARs can be minimized (but not altogether eliminated) by observing the following practices (by Tripathi, 2008): Avoid all inappropriate use of drugs. Use appropriate dose, route and frequency of drug administration. Elicit and take into consideration previous history of drug ARs. Elicit history of allergic diseases and exercise caution (drug allergy is more common in patients with allergic diseases). Rule out possibility of unwanted drug interactions. Use correct drug administration technique (e.g. i.v. injection of aminophylline must be slow). Carry out appropriate laboratory monitoring (e.g. prothrombin time and INR with acenocoumarol and warfarin; serum drug levels with lithium – 0.4–1 mmol/L).
Slide 9-

(1) Side effects are unwanted pharmacodynamic effects that occur at therapeutic doses. They can be predicted from the pharmacological profile of a drug. Very often reduction of the dose relieves the symptoms. In many cases a side effect may be based on the same action as the therapeutic effect, e.g. M-cholinolytics atropine is used in preanaesthetic medication for its antisecretory action produces xerostomia (dryness of mouth) as a side effect. Side effect may also be based on a different peculiarity of drug action, e.g. estrogens cause nausea which is unrelated to their main antiovulatory action. Atropine
Slide 10-

(2) Secondary effects are indirect consequences of a primary action of the drug, e.g. suppression of bacterial flora by aminopenicillins, cephalosporins, tetracyclines, chloramphenicol, fluoroquinolones, or co-trimoxazole results in the development of endogenous superinfections. (3) Toxic effects are the result of excessive pharmaco- logical action of the drug due to overdosage or prolonged use. Overdosage may be absolute (accidental, homicidal, suicidal) or relative (e.g. usual dose of aminoglycoside antibiotics in the presence of renal failure). Toxic effects are predictable and dose related. They result from functional alteration (in high dose atropine causes delirium) or drug- induced tissue damage (hepatic paracetamol necrosis).
Slide 11-

Acute paracetamol poisoning occurs especially in small children who have low hepatic glucuronide conjugating ability. If a large dose (> 150 mg/kg or > 10 g in adult) is taken, serious toxicity can occur. The letal dose is 250 mg/kg. N-acetyl-p-benzoquinoneimine (NABQI) is a highly reactive metabolite of paracetamol which is detoxified by conjugation with glutathione. When a very large doses of paracetamol are taken, the glucuroconjugation capacity is saturated, more NABQI is formed, hepatic glutathione is depleted and NABQI binds covalently to proteins in liver cells and renal tubules causing necrosis. In chronic alcoholics even 5 g/d paracetamol taken for a few days can result in hepatotoxicity (because ethanol induces CYP2E1&1A2 that metabolize paracetamol, to NABQI). Treatment needs activated charcoal, given orally or through the tube to prevent GI absorption, and for an exogenious donor of –SH groups – acetylcysteine is used (150 mg/g by i.v. infusion).
Slide 12-

Metabolism of Paracetamol (Acetaminophen) to hepatotoxic metabolites: NABQI…,… etc. (GSH – glutathione) Daily dose > 7.5 g: hepatotoxicity and nephrotoxicity NABQI Acetylcysteine and GSH contain –SH groups. Basic & Clinical Pharmacology – 10th Ed. (2007):
Slide 13-

Poisoning may result from dosages of drugs. Specific antidotes (receptor antagonists, chelating agents, or specific antibodies) are available only for few poisons. General supportive and symptomatic treatment includes: Termination of exposure. Prevention of GI absorption of ingested poisons with suspension of 20–40 g of activated charcoal in 200 ml water. Maintenance of patient airway (artificial respiration, if needed). Maintenance of blood pressure and heart beat by fluid infusion, pressor agents, cardiac stimulants, if needed. Hastening elimination of poison by inducing diuresis (furosemide, mannitol), altering urinary pH (alkalinisation for acidic drugs, acidification for basic drugs), haemodialysis and haemoperfusion (passage of blood through a column of charcoal or absorbent resin)
Slide 14-

(4) Intolerance is the appearance of characteristic toxic effects of a drug in a patient at therapeutic doses, e.g. only a few doses of carbamazepine may cause ataxia in some people; one tablet of chloroquine (250 mg) may cause vomiting and abdominal pain in some individuals. Intolerance indicates a low threshold of the individual to the action of drugs. (5) Allergic reactions occur only in a small part of the population exposed to the drug. Prior sensitization is needed and a latent period of at least 1–2 weeks is required after the first exposure. The drug or its metabolites act as antigen (AG) or more commonly hapten (incomplete AG – drug with small molecules which become antigenic only
Slide 15-

after binding with an endogenous protein) and induce production of antibody (AB)/sensitized lymphocytes. Chemically related drugs often show cross sensitivity. One drug can produce different types of allergic reactions. The course of drug allergy is variable. An individual previously sensitive to a drug may subsequently tolerate it without a reaction. There are several types of allergic reactions: humoral (type I–III) cell mediated (type IV).
Slide 16-

ppt slide no 16 content not found
Slide 17-

Type I (anaphylactic) reactions – immediate hypersensitivity. Drug-specific antibodies of the IgE type combine via their Fc moiety with receptors on the surface of mast cells. On exposure to the drug, AG/AB reaction takes place on the mast cell surface releasing mediators (histamine, 5-HT, LT-C4, LT-D4, PGs, PAF, etc.) resulting in urticaria, itching, angioedema, asthma, rhinitis, or anaphylactic shock. The manifestations occur quickly after challenge.
Slide 18-

ACE inhibitors – swelling of lips
Slide 19-

Type II (cytolytic) reactions Complexes drug / antibody (IgG) bind to receptors located on the surface of blood cells. In reexposure of drug on the surface of these cells develops AG/AB reaction, complement system (representing circulating in an inactive form of protein) is activated and this causes cytolysis: thrombocytopenia, agranulocytosis, aplastic anaemia, haemolysis, organ damage (liver, kidney, muscle), systemic lupus erythematosus.
Slide 20-

ppt slide no 20 content not found
Slide 21-

Type III (immune complex vasculitis) reactions are mediated by circulating antibodies (predominantly IgG). AG/AB complex binds complement and precipitates on vascular endothelium giving rise to a destructive inflammatory response. Manifestations are rashes, serum sickness (fever, arthralgia, lymphadenopathy), polyarteriitis nodosa, Stevens–Johnson syndrome (erythema muliforme, arthritis, nephritis, myocarditis, mental symptoms). These symptoms usually subsides in 1–2 weeks.
Slide 22-

Stevens–Johnson syndrome after oral intake of Co-trimoxazole (Color Atlas and Synopsis of Clinical Dermatology, 1999)
Slide 23-

Type IV (delayed hypersensitivity) reactions. They are mediated through production of sensitized T-lymphocytes carrying receptors for the AG. On contact with AG T-lym- phocytes produce lymphokines which attract granulocytes and generate an inflammatory response, e.g. contact der- matatitis, some rashes, fever, photosensitization. These types of allergic reactions generally take > 12 h to develop. Treatment of drug allergy The offending drug must be immediately stopped. Most mild ARs (some skin rashes) subside without treatment. Antihistamine (H1-blockers desloratadine, levocetirizine) are beneficial in type I reactions (urticaria, rhinitis,
Slide 24-

swelling of lips) and some skin rashes. In case of anaphylactic shock or angioedema of the larynx: a) Put the patient in reclining position, administer oxygen and perform cardiopulmonary resuscitation if required. b) Inject adrenaline 0.5 mg/1 ml i.m. (not i.v.); repeat every 5 to 10 min if the patient does not improve. This is the only life-saving measure. c) Administer an H1-blocker (e.g. chlorpheniramine 10–20 mg i.m. or slow i.v.). It may have an adjuvant value. d) In severe/recurrent cases inject slow i.v. methylpredni- solone or betamethasone. It acts slowly but is especially valuable for prolonged reactions and in asthmatics.
Slide 25-

Instructional Video for ANAPEN®: http://www.youtube.com/watch?v=ZR5c5VP2rOs I.M. Pre-filled syringes: Anapen® and EpiPen®: I.M.
Slide 26-

(Tripathi, 2008) Skin test (intradermal, patch) or intranasal test may usually forewarn in about 10% of cases with Type I hypersensitivity but not in other types.
Slide 27-

ppt slide no 27 content not found
Slide 28-

(6) Idiosyncrasy is genetically determined abnormal reactivity to a drug and other xenobiotics. Certain ARs of some drugs are largely restricted to individuals with a particular genotype. Acetylation is an important route of metabolism for many drugs that possess an amine (– NH2) group. Most individuals are either rapid or slow acetylators but the proportion of each varies greatly between races. Some 90% of Japanese are rapid acetylators whereas in Western populations the proportion is 50% or less. Isoniazid may cause peripheral neuropathy in slow acetylators on standard doses
Slide 29-

and pyridoxine is added to the antituberculosis regimen where there is a special risk, e.g. in diabetes, alcoholism, renal failure. Acute hepatocellular necrosis with isoniazid is more common in rapid acetylators, perhaps because they more readily form a hepatotoxic metabolite. Sulphasalazine (used for rheumatoid arthritis) causes ARs more frequently in slow acetylators, probably because it forms sulphapyridine, a component which is inactivated by acetylation. Bacterial resistance to drugs is genetically determined and is of great clinical importance.
Slide 30-

Individuals who are Glucose-6-phosphate dehydrogenase (G6PD) deficient may suffer from acute haemolysis if they are exposed to certain oxidant substances, including drugs (dapsone, methylene blue, nitrofurantoin, primaquine, fluoroquinolone, some sulphonamides). Characteristically there is an acute haemolytic episode 2–3 days after starting the drug. The haemolysis is self-limiting, only older cells with least enzymes being affected. The condition is common in Africa, the Mediterranean, the Middle East, and South East Asia.
Slide 31-

Porphyrins represent precursors of haem. But in people with porphyria the various porphyrins accumulate. Acute porphyrias are characterized by severe attacks of neurovisceral dysfunction precipitated principally by a wide variety of drugs (barbiturates, sulphonamides, hormonal contraceptives), some mushrooms, infections, and alcohol too. Certain peculiarities of an individual (for which no definite genotype has been described) are included among idiosyncratic reactions, e.g. phenobarbital causes excitement and mental confusion in some patients. The porphyrias comprise a number of rare, genetically determined enzyme defects in haem biosynthesis.
Slide 32-

Porphyria cutanea tarda. Periorbital and molar violaceous coloration, hyperpigmentation, and hypertrichosis on the face; bullae, crusts, and scars on the dorsa of the hands.
Slide 33-

Amanita phalloides can cause porphyria.
Slide 34-

(7) Drug dependence is a state arising from repeated, periodic or continuous administration of a drug, that results in harm to the individual and sometimes to society (Bennett ad Brown, 2003).The subject feels a desire, need, or compulsion to continue using the drug and feels ill if ab- ruptly deprived of it (abstinence or withdrawal syndrome). Drug dependence is characterized by: • Psychological dependence: there is emotional distress if the drug is withdrawn. • Physical dependence: there is a physical illness if the drug is withdrawn. • Tolerance.
Slide 35-

Psychological dependence develops when an individual believes that the optimal state of wellbeing is achieved only through the action of drugs. It may start as liking for the drug effects and may progress to compulsive drug use in some individuals. The intensity of psychological dependence may vary from desire to craving. Reinforcement is the ability of a drug to produce effects that make the user wish to take it again. Opioids, cocaine, and amphetamine are strong reinforcers, while benzodiazepines are week reinforcers.
Slide 36-

Physical dependence is an altered physiological state produced by repeated administration of a drug which necessitates the continued presence of the drug to maintain physiological equilibrium. Discontinuation of the drug results in a characteristic withdrawal (abstinence) syndrome. Drugs producing physical dependence are depressants of CNS: opioids (morphinomimetics), barbiturates, benzodiazepines, alcohol. Central nervous stimulants such as amphetamines and cocaine produce little or no physical dependence.
Slide 37-

Physical dependence
Slide 38-

ppt slide no 38 content not found
Slide 39-

Drug abuse means the use of psychotropic substances in a way that would “constitute a public health and social problem”. For a regulatory agency “drug abuse” refers to any use of an illicit drug. Drug addiction is a pattern of compulsive drug use characterized by overwhelming involvement with the use of a drug. Amphetamines, cocaine, cannabis, LSD are drugs which produce addiction but little or no physical dependence. Drug habituation is less intensive involvement with the drug, so that its withdrawal produces only mild discomfort without physical dependence (e.g. tea, coffee, tobacco).
Slide 40-

Types of drug dependence (Bennett, Brown, 2003)  Morphine or Heroin type: — psychological dependence severe — physical dependence severe; develops quickly — tolerance marked — cross-tolerance with related drugs — naloxone induces abstinence syndrome.  Barbiturate-type: — psychological dependence severe — physical dependence very severe; develops slowly at high doses — tolerance less marked than with morphine — cross-tolerance with alcohol and benzodiazepines
Slide 41-

Cocaine
Slide 42-

ppt slide no 42 content not found
Slide 43-

 Amphetamine-type: — psychological dependence severe — physical dependence slight: psychoses occur during use — tolerance occurs.  Cannabis-type: — psychological dependence — physical dependence dubious (no characteristic abstinence syndrome) — tolerance occurs.  Cocaine-type: — psychological dependence severe — physical dependence slight — tolerance slight (to some actions).
Slide 44-

 Alcohol-type: — psychological dependence severe — physical dependence with prolonged heavy use — cross-tolerance with other sedatives.  Tobacco-type: — psychological dependence — physical dependence.  Drug mixtures: Barbiturate-amphetamine mixtures induce a characteristic alteration of mood that does not occur with either drug alone — psychological dependence strong — physical dependence occurs — tolerance occurs.  Heroin-cocaine mixtures: similar characteristics.
Slide 45-

ppt slide no 45 content not found
Slide 46-

ppt slide no 46 content not found
Slide 47-

ppt slide no 47 content not found
Slide 48-

Nicotine is an enzyme inducer.
Slide 49-

ppt slide no 49 content not found
Slide 50-

ppt slide no 50 content not found
Slide 51-

ppt slide no 51 content not found
Slide 52-

karoshi Modern obsessions
Slide 53-

ppt slide no 53 content not found
Slide 54-

ppt slide no 54 content not found
Slide 55-

ppt slide no 55 content not found
Slide 56-

(8) Drug withdrawal syndrome – sudden interruption of therapy with certain drugs (glucocorticoids, antiepileptic drugs, CV drugs, etc.) usually results in ARs, mostly in the form of worsening of the clinical condition for which the drug was being used. Examples: Frequency of seizures may increase on sudden withdrawal of an antiepileptic drug. Worsening of angina pectoris or acute myocardial infarction may result from stoppage of beta-blockers or nitrovasodilators. Severe hypertension and sympathetic overactivity may occur shortly after discontinuing clonidine. In all these cases, it is very important to keep patient’s compliance and/or to stop the drug gradually.
Slide 57-

(9) Effects of prolonged administration: Chronic organ toxicity (types C and D reactions) Eye. Toxic cataract can be due to chloroquine and related drugs, adrenal steroids (topical and systemic), phenothiazines and alkylating agents. Corneal opacities occur with phenothiazines, amiodarone, and chloroquine. Retinal injury occurs with thioridazine (particularly of the antipsychotics), chloroquine, and indometacin. Nervous system. Tardive dyskinesias occur with neuroleptics; polyneuritis with isoniazid, metronidazole, or zalcitabine; optic neuritis with ethambutol.
Slide 58-

ppt slide no 58 content not found
Slide 59-

ppt slide no 59 content not found
Slide 60-

Polyneuritis Tardive dyskinesia
Slide 61-

Pulmotoxicity. Amiodarone may cause pulmonary fibrosis. Sulphasalazine is associated with fibrosing alveolitis. Nephrotoxicity: Aminoglycosides, polymyxines, gold salts. Hepatotoxicity: Methotrexate, paracetamol, halothane. Thyreotoxicity: Amiodarone Carcinogenesis. The principal mechanisms are: Alteration of DNA (genotoxicity, mutagenicity). •Immunosuppression. A wide range of cancers develop in immunosuppressed patients, e.g. after organ transplantation and cancer chemotherapy. •Hormonal. Long-term use of estrogen replacement in postmenopausal women induces endometrial cancer.
Slide 62-

Тhe biggest medical tragedy of modern times (10) Teratogenisity represents the the fetal abnormalities of a drug, administered to the pregnant mother (by Tripathi, 2008). The placenta does not strictly constitute a barrier and any drug can cross to a greater or lesser extent. The embryo is one of the most dynamic biological systems and in contrast to adults, drug effects very often are irreversible. The thalidomide disaster (1958–1962) resulting in 10 000 of babies born with phocomelia and other defects focused attention to these types of drug adverse effects.
Slide 63-

The Australian obstetrician William McBride and the German pediatrician Widukind Lenz suspected a link between birth defects and thalidomide, and this was proved by Lenz in 1961. McBride was later awarded a number of honours including a medal and prize money by the L'Institut de la Vie in Paris.
Slide 64-

Phocomelia – seal-like limbs (W. Lenz, K. Knapp. Thalidomide embryopathy. Dtsch Med Wochenschr. 1962 Jun 15; 87:1232–42). Germany: 2500 babies
Slide 65-

UK: 456 babies
Slide 66-

- Absence of the auricles with deafness. - Defects of the muscles of the eye and of the face. - Absence or hypoplasia of arms, preferentially affecting the radius and the thumb. - Thumbs with three joints. - Defects of the femur and of the tibia. - Malformations of the heart, the bowel, the uterus, and the gallbladder. W. Lenz
Slide 67-

In 1962, the United States Congress enacted laws requiring tests for safety during pregnancy before a drug can receive approval for sale in the U.S. USA: 17 babies
Slide 68-

ppt slide no 68 content not found
Slide 69-

ppt slide no 69 content not found
Slide 70-

Thalidomide is racemic: it contains both left- and right-handed isomers. The (R) enantiomer is effective against morning sickness. The (S) is teratogenic and causes birth defects. The enantiomers can interconvert in vivo. The (S) enantiomer intercalates (inserts) into the DNA in G–C (guanine – cytosine) rich regions. (S)-thalidomide (R)-thalidomide
Slide 71-

Drugs can affect the fetus at the following stages: Fertilization and implantation – from conception to 14–17 days: failure of pregnancy (which often goes unnoticed). Embryogenesis (organogenesis) – between 15–18 to 55 days of gestation: most vulnerable period, major morphologic deformities are produced. Fetogenesis (growth and development) – from 56 days of gestation to birth: developmental and functional abnormali- ties can occur, e.g. aminoglycosides can cause ototoxicitiy, ACE inhibitors – hypoplasia of cranium, lungs, and kidneys; NSAIDs may induce premature closure of d. arteriosus. The type of malformation depends on the drug as well as the stage of exposure to the teratogen.
Slide 72-

Embryogenesis Dorland’s Illustrated Medical Dictionary (2003, 2004)
Slide 73-

ppt slide no 73 content not found
Slide 74-

(By Moore KL: The Developing Human: Clinically Oriented Embryology, 4th ed. Saunders, 1988.) Schematic diagram of critical periods of human development
Slide 75-

A B C D X Pregnancy and Lactation Risk Categories (PRCs and LRCs The FDA (USA) has established 5 categories to indicate the potential of systematically absorbed drugs for causing birth defects. The key differentiation among the categories rests upon the reliability of documentation and the risk:benefit ratio (Lacy et al., 1998).
Slide 76-

PRC A: Controlled studies in pregnant women fail to demonstrate a risk to the fetus in the first trimester with no evidence of risk in later trimesters. Examples: Folic acid, T4, Magnesium sulfate (inj.!) PRC B: The animal-reproduction studies have not demonstrated a fetal risk but there are no controlled studies in pregnant women. Examples: penicillins, erythromycin, paracetamol, lidocaine.
Slide 77-

PRC C: The studies in animals have revealed ARs on the fetus (teratogenic, embryocidal, or other effects) and there are no controlled studies in women, or studies in women are not available. The drug should be given only if the potential benefits justify the potential risk to the fetus. Examples: atropine, adrenaline, thiopental, bisoprolol. PRC D: There is positive evidence of human fetal risk, but the benefits from use in pregnant women may be acceptable despite the risk (e.g. if the drug is needed in a life-threatening situation or for a serious disease for which safer drugs that can be used are ineffective). Examples: phenytoin, valproate, diazepam, lorazepam.
Slide 78-

С Phenytoin syndrome
Slide 79-

PRC X: Studies in animals or human beings have demonstrated fetal abnormalities and the risk of the use of the drug in pregnant women clearly outweighs any possible benefit. The drug is contraindi- cated in women who are or may become pregnant. Examples: thalidomide, estrogens, isotretinoin, ergometrine.
Slide 80-

(Tripathi, 2008)
Slide 81-

Eythroxylon coca L. Cocaine
Slide 82-

ppt slide no 82 content not found
Slide 83-

Lactation Risk Categories – LRC)
Slide 84-

ppt slide no 84 content not found
Slide 85-

(11) Drug-induced diseases are also called iatrogenic (physician induced) diseases. They represent functional disturbances (diseases) caused by drugs which persist even after the offending remedy has been withdrawn and largely eliminated. Examples: Parkinsonism by phenothiazine and other neuroleptics. Hepatitis by isoniazid. Peptic ulcer by salicylates, glucocorticoids, or reserpine Aplastic anaemia by chloramphenicol etc.
Slide 86-

Polypragmasy
Slide 87-

Parkinsonism
Slide 88-

ppt slide no 88 content not found
Slide 89-

ppt slide no 89 content not found
Slide 90-

ppt slide no 90 content not found
Slide 91-

ppt slide no 91 content not found
Slide 92-

www.medpharm-sofia.eu